NEW YORK (GenomeWeb News) – A non-profit organization called the National Biomarker Development Alliance has launched to develop standards and guidelines for supporting biomarker development and use, the NBDA said today.

The NBDA was created to "address the complex and urgent challenge of creating the standards to support end-to-end evidence-based biomarker development," and will engage partners from industry, academia, government, and patient groups, NBDA said.

The alliance was established and launched today by the Research Collaboratory at Arizona State University

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.